L.I.A. Pure Capital Ltd - 09 Feb 2026 SCHEDULE 13G/A Report for Clearmind Medicine Inc. Common Shares, no par value per share (CMND)

Filing Manager
L.I.A. Pure Capital Ltd
Reporting Manager
L.I.A. Pure Capital Ltd.
Security
Clearmind Medicine Inc. Common Shares, no par value per share
Symbol
CMND
Shares outstanding
2,174,400 shares
Disclosed Ownership
108,720 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
16 Mar 2026, 11:12:02 UTC
Date of event
09 Feb 2026
Previous filing
10 Dec 2025
SEC
View on sec.gov

Quoteable Key Fact

"L.I.A. Pure Capital Ltd disclosed 5% ownership in Clearmind Medicine Inc. Common Shares, no par value per share (CMND) on 09 Feb 2026."

Quick Takeaways

  • L.I.A. Pure Capital Ltd filed SCHEDULE 13G/A for Clearmind Medicine Inc. Common Shares, no par value per share (CMND).
  • Disclosed ownership: 5%.
  • Date of event: 09 Feb 2026.

What Changed

  • Previous schedule filing date: 10 Dec 2025.
  • Current filing was accepted on 16 Mar 2026, 11:12.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
L.I.A. Pure Capital Ltd. 5% 108,720 108,720 0 /s/ Kfir Silberman Kfir Silberman/Chief Executive Officer